OTCMKTS:AMFPF Amplifon (AMFPF) Stock Price, News & Analysis → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free AMFPF Stock Alerts $32.20 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$32.20▼$32.2050-Day Range$29.87▼$32.2052-Week Range$27.90▼$35.88VolumeN/AAverage Volume41 shsMarket Capitalization$7.29 billionP/E Ratio41.28Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort Interest Get Amplifon alerts: Email Address Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. About Amplifon Stock (OTCMKTS:AMFPF)Amplifon S.p.A. engages in the distribution of hearing solutions and the fitting of customized products that help people rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Ampli-easy, Ampli-connect, Ampli-energy, and Ampli-mini hearing devices. It also operates Ampli-care, a platform to deliver audiological care experience; and Amplifon App to manage the device functions in real-time directly from smartphone. Amplifon S.p.A. was founded in 1950 and is headquartered in Milan, Italy. Amplifon S.p.A.Read More AMFPF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AMFPF Stock News HeadlinesApril 23, 2024 | americanbankingnews.comAnalyzing Amplifon (OTCMKTS:AMFPF) & 5N Plus (OTCMKTS:FPLSF)March 15, 2024 | msn.comItaly's Amplifon to boost voting rights using new capital markets billApril 25, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.March 7, 2024 | msn.comAmplifon sees U.S. demand lifting revenue growth in 2024January 18, 2024 | financialpost.comAmplifon Recognized as 2024 Top Employer for the First Time in North America and CanadaJanuary 18, 2024 | tmcnet.comAmplifon and Miracle-Ear Recognized as 2024 Top Employers in the U.S. and, for the First Time, in North AmericaNovember 29, 2023 | finance.yahoo.comAmplifon, Hearing Care Experts, Expands Its Footprint in Alberta and Reaches More Than 130 Stores in CanadaOctober 30, 2023 | msn.comAmplifon lowers profit forecast on weak European market, shares dropApril 25, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.October 30, 2023 | news.yahoo.comAmplifon lowers profit forecast on weak demand, global uncertaintyOctober 29, 2023 | markets.businessinsider.comWhat Wall Street expects from Amplifon Post Frazionamento's earningsAugust 22, 2023 | finance.yahoo.comAmplifon Australia Opens Its Headquarters in Central MelbourneJuly 27, 2023 | markets.businessinsider.comAmplifon Post Frazionamento earnings preview: what Wall Street is expectingMay 31, 2023 | benzinga.comAmplifon named to Newsweek's list of the Top 100 Global Most Loved Workplaces for 2023May 2, 2023 | msn.comItalian hearing aid maker Amplifon expects higher 2023 earningsFebruary 19, 2023 | barrons.comAmplifon S.p.A.February 17, 2023 | seekingalpha.comSonova: Buy This Beneficiary Of An Aging PopulationJanuary 18, 2023 | finance.yahoo.comAmplifon Americas Recognized as a ‘Top Employer’ in the U.S.January 17, 2023 | wsj.comAmplifon Americas Recognized as a 'Top Employer' in the U.S.September 20, 2022 | seekingalpha.comCAH Cardinal Health, Inc.July 30, 2022 | seekingalpha.comAmplifon S.p.A. (AMFPF) CEO Enrico Vita on Q2 2022 Results - Earnings Call TranscriptMay 3, 2022 | seekingalpha.comAmplifon S.p.A. (AMFPF) CEO Enrico Vita on Q1 2022 Results - Earnings Call TranscriptMay 3, 2022 | uk.finance.yahoo.comItaly's Amplifon confirms 2022 guidanceMarch 2, 2022 | markets.businessinsider.comHere's what Wall Street expects from Amplifon Post Frazionamento's earnings reportFebruary 28, 2022 | tmcnet.comWorld Hearing Day 2022: Amplifon Joins "To Hear For Life, Listen With Care" Global WHO CampaignSeptember 13, 2021 | nasdaq.comAmplifon sees 'high single digit' growth in revenues in 2022 and 2023September 13, 2021 | nasdaq.comAmplifon sees 'high single digit' sales growth in 2022, 2023See More Headlines Receive AMFPF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Amplifon and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/25/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Private households Sub-IndustryN/A Current SymbolOTCMKTS:AMFPF CUSIPN/A CIKN/A Webcorporate.amplifon.com Phone(390) 257-4721FaxN/AEmployees13,195Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.78 Trailing P/E Ratio41.28 Forward P/E Ratio32.53 P/E GrowthN/ANet Income$188.09 million Net Margins7.44% Pretax MarginN/A Return on Equity16.57% Return on Assets4.83% Debt Debt-to-Equity Ratio0.61 Current Ratio0.48 Quick Ratio0.41 Sales & Book Value Annual Sales$2.23 billion Price / SalesN/A Cash Flow$1.97 per share Price / Cash Flow16.34 Book Value$4.84 per share Price / Book6.65Miscellaneous Outstanding SharesN/AFree FloatN/AMarket Cap$7.29 billion OptionableNot Optionable Beta0.42 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Enrico Vita (Age 55)CEO, MD, GM & Executive Director Comp: $3.37MMr. Gabriele Galli (Age 55)Executive of Financial Reporting & Corporate Accounting Information and CFO Mr. Alessandro Bonacina (Age 46)Chief Marketing, Technology & Innovation Officer Mr. Andrea CiccoliniChief Information & Transformation OfficerMs. Francesca RambaudiInvestor Relations DirectorMr. Salvatore RiccoChief Communication OfficerMs. Francesca Morichini (Age 46)Chief HR Officer Mr. Cristian Finotti (Age 55)Chief Procurement & Supply Chain Officer Mr. Iacopo Lorenzo Pazzi (Age 52)Executive Vice President of EMEA Mr. Riccardo Cattaneo (Age 61)Chief Regulatory Officer More ExecutivesKey CompetitorsRamsay Health CareOTCMKTS:RMYHYAurora CannabisOTCMKTS:ACBFFSWEDISH ORPHAN/SOTCMKTS:SWTUYSino BiopharmaceuticalOTCMKTS:SBMFFAspen PharmacareOTCMKTS:APNHYView All Competitors AMFPF Stock Analysis - Frequently Asked Questions Should I buy or sell Amplifon stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amplifon in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" AMFPF shares. View AMFPF analyst ratings or view top-rated stocks. How have AMFPF shares performed in 2024? Amplifon's stock was trading at $27.90 at the beginning of 2024. Since then, AMFPF stock has increased by 15.4% and is now trading at $32.20. View the best growth stocks for 2024 here. Are investors shorting Amplifon? Amplifon saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 3,035,600 shares, an increase of 6.2% from the March 31st total of 2,857,900 shares. Based on an average trading volume of 100 shares, the short-interest ratio is presently 30,356.0 days. View Amplifon's Short Interest. How do I buy shares of Amplifon? Shares of AMFPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:AMFPF) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplifon S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
